ArticleSkeletal radiology2026
Atypical "opened-bottle" proximal tibial fractures in young male patients with growth hormone and aromatase inhibitor treatment: case series.
Article in Skeletal radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Atypical proximal tibial fractures in adolescents are rare, particularly when linked to hormonal therapy for short stature. This case series reports the clinical and imaging features of atypical proximal tibial and distal femoral physeal fractures in male adolescents undergoing combined growth hormone (GH) and aromatase inhibitor (AI) therapy for idiopathic short stature. We report three cases of skeletally immature male adolescents (ages 12-16) treated with GH and anastrozole who presented with acute leg pain following low-energy trauma during soccer. Computed tomography (CT) imaging identified fractures through the physis and metaphysis with characteristic anterior displacement-resembling an "opened-bottle" configuration. Fractures occurred during periods of rapid growth with delayed physeal closure and reduced bone mineral density. Two cases were managed surgically, and one conservatively. Salter-Harris and Ogden classification systems were used. These cases highlight the potential impact of growth-modulating therapies on bone integrity, particularly their influence on the growth plate and overall bone strength, which may increase fracture risk. Imaging and clinical findings emphasize the role of hormone-related delayed physeal closure and altered biomechanics in fracture development. This report aims to raise awareness of this complication and explores possible mechanisms connecting therapy to these atypical injuries.
Indexed as
Identifiers
40928549What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.